Middletown, DE -- (SBWIRE) -- 09/25/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Questcor Pharmaceuticals Inc(NASDAQ:QCOR), Zions Bancorporation(NASDAQ:ZION), BioMarin Pharmaceutical Inc.(NASDAQ:BMRN)
Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA) gained volume of 2.31 million shares and the average volume of the stock remained 2.75 million shares. The 52 week range of the stock remained $15.35 - $25.40 and the day range was $19.99 - $20.40.The stock opened the session at $20.33, and closed the session at $20.01. The stock showed a negative performance of -1.06% in previous trading session. ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. The company focuses on commercializing Iclusig (ponatinib), a cancer medicine; and developing additional molecularly targeted therapies to treat patients with blood cancers and solid tumors.
Has ARIA Found The Bottom and Ready To Move Up? Find Out Here
In previous session, Questcor Pharmaceuticals Inc(NASDAQ:QCOR) traded 2.33 million shares and the average volume of the stock remained 1.51 million shares. The 52 week range of the stock remained $17.25 - $74.76. The stock was a bull and advanced +1.08%, while its closing price stayed at $55.93. The market capitalization of the stock remained 3.36 billion. The half-yearly trend of the stock remained positive +71.88%. Questcor Pharmaceuticals, Inc., a biopharmaceutical company, provides drugs for the treatment of multiple sclerosis, nephrotic syndrome, and infantile spasms indications. It primarily offers H.P. Acthar Gel, an injectable drug for the treatment of acute exacerbations of multiple sclerosis in adults.
For How Long QCOR will fight for Profitability? Read This Trend Analysis report
Zions Bancorporation(NASDAQ:ZION) volume of the stock was 2.27 million shares in the most recent session and the average volume remained 1.69 million shares. The stock plunged -1.25% and finished the prior session at the closing price of $27.62. The stock traded 2.27 million shares in its previous trading session and its average volume remained 1.69 million shares. Zions Bancorporation, a financial holding company, provides banking and related services in the United States. It offers community banking services, including small and medium-sized business and corporate banking; commercial and residential development, construction, and term lending; retail banking.
Why Should Investors Buy ZION After the Recent Fall? Just Go Here and Find Out
BioMarin Pharmaceutical Inc.(NASDAQ:BMRN) traded with volume of 2.26 million shares and the average volume of the stock remained 1.64 million shares. The stock decreased -4.22% and finished the trading at $73.70. The market capitalization of the stock remained 10.33 billion. The beta of the stock remained 1.19. BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. The company?s commercial products include Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase enzyme used for the treatment of mucopolysaccharidosis VI.
Will BMRN Get Buyers Even After The Recent Rally? Find Out Here
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)